Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSreedharan, Sidha-
dc.contributor.authorLi, Ning-
dc.contributor.authorLittlejohn, Geoff-
dc.contributor.authorBuchanan, Russell R C-
dc.contributor.authorNikpour, Mandana-
dc.contributor.authorMorand, Eric-
dc.contributor.authorGolder, Vera-
dc.contributor.authorHoi, Alberta Y-
dc.identifier.citationArthritis research & therapy 2022-06-22; 24(1): 150en
dc.description.abstractHealthcare quality for systemic lupus erythematosus (SLE) is a modifiable target for improving patient outcomes. We aimed to assess the quality of care processes in different clinic settings, comparing a subspecialty lupus clinic with hospital-based and private general rheumatology clinics. Patients with SLE (n = 258) were recruited in 2016 from a subspecialty lupus clinic (n = 147), two hospital general rheumatology clinics (n = 56) and two private rheumatology clinics (n = 55). Data were collected from medical records and patient questionnaires. Quality of care was assessed using 31 validated SLE quality indicators (QI) encompassing diagnostic work-up, disease and comorbidity assessments, drug monitoring, preventative care and reproductive health. Per-QI performance was measured as a percentage of patients that met the QI relative to the number of patients eligible. Per-patient QI performance was calculated as a percentage of QIs met relative to the number of eligible QIs for each patient. Per-QI and per-patient QI performance were compared between the three clinic settings, and multiple regression performed to adjust for sociodemographic, disease and healthcare factors. Per-QI performance was generally high across all clinic settings for diagnostic work-up, comorbidity assessment, lupus nephritis, drug monitoring, prednisolone taper, osteoporosis and pregnancy care. Median [IQR] per-patient performance on eligible QIs was higher in the subspeciality lupus clinic (66.7% [57.1-74.1]) than the hospital general rheumatology (52.7% [47.5-58.1]) and private rheumatology (50.0% [42.9-60.9]) clinics (p <0.001) and the difference remained significant after multivariable adjustment. The subspecialty lupus clinic recorded higher per-QI performance for documentation of disease activity, disease damage, cardiovascular risk factor and drug toxicity assessments, pre-immunosuppression hepatitis and tuberculosis screening, new medication counselling, vaccinations, sun avoidance education and contraception counselling. SLE patients managed in a subspecialty lupus clinic recorded higher per-patient QI performance compared to hospital general rheumatology and private rheumatology clinics, in part related to better documentation on certain QIs.en
dc.subjectQuality indicatorsen
dc.subjectQuality of careen
dc.subjectSystemic lupus erythematosusen
dc.titleAssociation of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional study.en
dc.typeJournal Articleen
dc.identifier.journaltitleArthritis research & therapyen
dc.identifier.affiliationThe University of Melbourne at St Vincent's Hospital Melbourne, Melbourne, Australiaen
dc.identifier.affiliationMonash University, Melbourne, Australiaen
dc.identifier.affiliationMonash Health, Melbourne, Australiaen
dc.identifier.affiliationAustin Healthen
dc.identifier.affiliationMonash University, Melbourne, Australia. Monash Health, Melbourne, Australia.
dc.identifier.pubmedid35733186, Russell R C
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Oct 1, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.